What are the side effects of DNSP-11?
The most commonly reported DNSP-11 side effects are limited human safety data, theoretical effects on dopaminergic signaling, injection-site irritation. Most are mild and tend to be dose dependent. It is generally avoided with active psychiatric medication regimen affecting dopamine. Human clinical evidence for DNSP-11 is limited, so this reflects reported and observed effects, not a complete safety profile.
Reported DNSP-11 side effects
- Limited human safety data
- Theoretical effects on dopaminergic signaling
- Injection-site irritation
Who should avoid it
- Active psychiatric medication regimen affecting dopamine
- Pregnancy / nursing
- Anyone risk-averse to pre-clinical compounds
References
- Dopamine neuron stimulating actions of a GDNF propeptide — Bradley LH, Fuqua J, Richardson A, et al. (Gerhardt GA group). PLoS One, 2010
- Methodology and effects of repeated intranasal delivery of DNSP-11 in awake Rhesus macaques — Stenslik MJ, Evans A, Pomerleau F, et al. (Gerhardt GA, Bradley LH groups). Journal of Neuroscience Methods, 2018
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.
More on DNSP-11
Last updated 2026-06-06.